Showing results (81-90 of 127) with videos related to

Sort By:
Pageof 13
European Journal of Cancer (Oxford, England : 1990)|September 9, 2010
Diagnostic and prognostic role of plasma levels of two forms of cytokeratin 18 in patients with non-small-cell lung cancerLuigi De Petris, Eva Brandén, Richard Herrmann, et al.
Indian Journal of Experimental Biology|November 5, 2010
Screening of natural products for therapeutic activity against solid tumorsBassem S El-Menshawi, Walid Fayad, Khaled Mahmoud, et al.
Biochemical and Biophysical Research Communications|January 16, 2013
Piperlongumine induces inhibition of the ubiquitin-proteasome system in cancer cellsMalin Jarvius, Mårten Fryknäs, Pädraig D'Arcy, et al.
Stem Cells (Dayton, Ohio)|April 5, 2013
Alterations in the cellular immune compartment of patients treated with third-party mesenchymal stromal cells following allogeneic hematopoietic stem cell transplantationRegina Jitschin, Dimitrios Mougiakakos, Lena Von Bahr, et al.
Chemical Biology & Drug Design|April 10, 2015
Synthesis and evaluation of derivatives of the proteasome deubiquitinase inhibitor b-AP15Xin Wang, Pádraig D'Arcy, Thomas R Caulfield, et al.
Molecular Cancer Therapeutics|April 26, 2015
Three-Dimensional Cell Culture-Based Screening Identifies the Anthelmintic Drug Nitazoxanide as a Candidate for Treatment of Colorectal CancerWojciech Senkowski, Xiaonan Zhang, Maria Hägg Olofsson, et al.
Investigational New Drugs|November 27, 2012
Gambogic acid is cytotoxic to cancer cells through inhibition of the ubiquitin-proteasome systemJenny Felth, Karolina Lesiak-Mieczkowska, Padraig D'Arcy, et al.
Plos One|October 7, 2014
Elevation of proteasomal substrate levels sensitizes cells to apoptosis induced by inhibition of proteasomal deubiquitinasesChao Sun, Peristera Roboti, Marjo-Riitta Puumalainen, et al.
Cancer Letters|February 16, 2019
Proteasome inhibitor b-AP15 induces enhanced proteotoxicity by inhibiting cytoprotective aggresome formationEllin-Kristina Hillert, Slavica Brnjic, Xiaonan Zhang, et al.
Molecular Biology of the Cell|May 27, 2005
Doxorubicin requires the sequential activation of caspase-2, protein kinase Cdelta, and c-Jun NH2-terminal kinase to induce apoptosisTheocharis Panaretakis, Edward Laane, Katja Pokrovskaja, et al.
Pageof 13